Status: Recruiting
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
The purpose of this study is is to evaluate the efficacy and safety of veverimer in treating adults with moderate-to-severe chronic kidney disease (CKD) and metabolic acidosis.
Participants needed: 150
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Renibus Therapeutics, Inc.Updated: Jul 28, 2026Locations: 22
Eligibility criteria
Have provided written informed consent prior to participation in the study. [+7]
Any participant deemed by the Investigator to be an inappropriate candidate for... [+23]